Who We Are

At Longwood, our team finds strength in our diverse backgrounds and passion for innovation. We’re a team of doctors, investors, entrepreneurs, scientists, and life-long learners who are committed to discovering and building science-based companies that are working to change the world.

Team

Christoph Westphal

Christoph Westphal

MD, PhD
Co-Founder & General Partner
Bio

Rich Aldrich

MBA
Co-Founder & General Partner
Bio
David Steinberg

David Steinberg

MBA
General Partner
Bio

John Lawrence

MBA, CPA
Chief Financial Officer
Bio

Lea Hachigian

PhD
Principal
Bio
Aleks-Radovic-Moreno

Aleks Radovic-Moreno

PhD
Entrepreneur-in-Residence
Bio
Lucy Liu

Lucy Liu

PhD
Senior Associate
Bio

David Donabedian

PhD
Venture Partner
Bio

Arielle Jackson

Director, Investor Relations
Bio

Strategic Advisory Board

JJ Bienaime

Jean-Jacques Bienaimé

Chair & CEO, BioMarin; Director, BIO

James Foster

Chair, President & CEO, Charles River Laboratories

Laurie Glimcher

Laurie Glimcher, MD

President & CEO, Dana-Farber Cancer Institute; Harvard

Wyc Grousbeck

CEO, Boston Celtics; Managing Partner, Causeway Media Partners

Peter Hutt, LLB, LLM

Former FDA General Counsel; SAB: SIRT, Alnara, Axial
BOD: Momenta, Concert Pharmaceuticals

Rod MacKinnon, PhD

Nobel Laureate; Rockefeller University

John Maraganore, PhD

CEO, Alnylam; Chair Emeritus, BIO

Jim Mullen

James C. Mullen

Chair, Editas; former CEO, Biogen

Betsy-Nabel

Elizabeth Nabel, MD

President, Brigham Health

Stefan Oelrich

CEO, Bayer Pharmaceuticals

Al Sandrock, MD, PhD

EVP, Research & Development, Biogen

Paul Schimmel, PhD

NAS; Scripps; Co-Founder: Alnylam, Momenta, Sirtris

Phil Sharp, PhD

Nobel Laureate; NAS; Co-Founder: Biogen, Alnylam
SAB: Sirtris, Verastem

Roger Tung, PhD

Co-Founder, President & CEO, Concert Pharmaceuticals

Chris Walsh, PhD

Stanford, Harvard; NAS; Genzyme; SAB: Sirtris, Verastem, TScan

Susan Windham-Bannister, PhD

President Emeritus, Mass Life Science Center

Dane Wittrup

K. Dane Wittrup, PhD

MIT, Koch; Scientific Co-Founder: Immunitas

Kai Wucherpfennig

Kai Wucherpfennig, MD, PhD

Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute; Harvard, Broad; Scientific Co-Founder: Immunitas; SAB: TScan